Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management

AI Briefing

• – ALA-1000 effective in osteoarthritis pain management for at least 1 month
• – Study demonstrates favorable safety profile with repeated use
• – Improves functional mobility in client-owned dogs with osteoarthritis